Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the safety of topical FP1198 for the treatment of moderate to severe cyclic breast pain (cyclic mastalgia) and to examine the clinical activity of FP1198.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01105793
Study type Interventional
Source FemmePharma Global Healthcare, Inc.
Contact
Status Completed
Phase Phase 2
Start date June 2010
Completion date June 2011